Bevacizumab for the treatment of patients with advanced colorectal cancer
Pichon-Riviere A, Augustovski F, Garcia Marti S, Bardach A, Lopez A, Regueiro A, Glujovsky D, Aruj P, Calcagno J
 
 
Record Status

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

Citation
Pichon-Riviere A, Augustovski F, Garcia Marti S, Bardach A, Lopez A, Regueiro A, Glujovsky D, Aruj P, Calcagno J. Bevacizumab for the treatment of patients with advanced colorectal cancer. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No.147. 2008
Project page URL
http://www.iecs.org.ar/iecs-visor-publicacion.php?cod_ publicacion=765& amp;origen_ publicacion=publicaciones
Indexing Status
Subject indexing assigned by CRD
MeSH
Antibodies, Monoclonal; Antineoplastic Agents /therapeutic use; Colorectal Neoplasms /drug therapys
Language Published
Spanish
Country of organisation
Argentina
English Summary
English summary available
Address for correspondence
Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina, Tel: +54 11 49 66 00 82, Fax: +54 11 49 53 40 58 Email: info@iecs.org.ar
AccessionNumber
32009100107
Date abstract record published
08/07/2009
 
Health Technology Assessment (HTA) database
Copyright © 2026 Institute for Clinical Effectiveness and Health Policy (IECS)
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for HTA database users